Investors
Press Releases
Press releases issued by Palatin are accessible below. These press releases contain additional information about our business, clinical trial developments, research and development activities, financial achievements, and strategic partnerships.
Found 316 Results
Palatin Announces Positive End-of-Phase 2 Meeting with FDA on PL9643 for the Treatment of Dry Eye Disease
June 29, 2021
Palatin Reports Financial Results for the Third Fiscal Quarter of 2021 and Provides Corporate Update
May 17, 2021
Palatin to Report Third Quarter, Fiscal Year 2021 Results; Teleconference and Webcast to be held on May 17, 2021
May 13, 2021
Page 11 of 32